Teva Pharmaceutical's Turnaround Is Working. Here's When to Buy the Stock. [Globe and Mail, The (Toronto, Canada)]
Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
Last teva pharmaceutical industries limited american depositary shares earnings: 2/13 04:01 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.tevapharm.com
Company Research
Source: Globe and Mail, The
The company continues to effect a major pivot in its business. Teva Pharmaceutical Industries (NYSE: TEVA) will unveil its first-quarter results this Wednesday, April 29. Many Teva trackers will be watching for validation of the company's continuing strategic pivot. Perhaps it's a good idea to buy the veteran pharmaceutical company's stock in advance of the event. Let's explore. A pivotal period Teva's transformation strategy, the self-descriptive "Pivot to Growth," was formally announced in 2023. For years, the company has been the world's top manufacturer of generic drugs. In the days when that healthcare segment was relatively limited, Teva ruled its niche. But success attracts competition, and with market share to fight for, margins (and thus profits) started to fall. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need
Show less
Read more
Impact Snapshot
Event Time:
TEVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TEVA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TEVA alerts
High impacting Teva Pharmaceutical Industries Limited American Depositary Shares news events
Weekly update
A roundup of the hottest topics
TEVA
News
- Earnings Snapshot: Teva Pharmaceutical Industries tops Q1 estimates; maintains 2026 business outlook [Seeking Alpha]Seeking Alpha
- Medincell - UZEDY®: Q1 2026 Net Sales Reached $63M, Up 62% Year-on-Year [Yahoo! Finance]Yahoo! Finance
- Medincell - UZEDY®: Q1 2026 Net Sales Reached $63M, Up 62% Year-on-YearBusiness Wire
- Teva Delivers Strong Q1 2026 Results Driven by Innovative Portfolio Growth and Disciplined ExecutionGlobeNewswire
- Teva to Acquire Emalex Biosciences, Adding NDA-Ready, First-in-Class Therapy to Neuroscience Pipeline and Accelerating Teva's Pivot to Growth Strategy [Yahoo! Finance]Yahoo! Finance
TEVA
Earnings
- 4/29/26 - Beat
TEVA
Sec Filings
- 4/29/26 - Form 8-K
- 3/31/26 - Form DEFA14A
- 3/31/26 - Form ARS
- TEVA's page on the SEC website